28 June 2022Partnership Announcement

Follow the link to view the full news release. Stryker´s news release

An aneurysm occurs when part of a blood vessel becomes weak, causing the vessel to balloon or bulge and fill with blood. If left untreated, the aneurysm may continue to weaken until it bursts and bleeds. Brain aneurysms are the most life-threatening and cause almost 500,000 deaths worldwide each year¹.

The Stryker and Carmeda partnership will combine Stryker’s proven flow diverter technology with Carmeda’s active heparin coating to advance the treatment of brain aneurysms. Carmeda’s active heparin coating, the CARMEDA^® BioActive Surface, is also known as CBAS^® Heparin Surface.

_{1. Brain Aneurysm Foundation. Statistics and Facts Website. https://bafound.org/about-brain-aneurysms/brain-aneurysm-basics/brain-aneurysm-statistics-and-facts/ Accessed July 25, 2020}